Please login to the form below
LifeArc
This page shows the latest LifeArc news and features for those working in and with pharma, biotech and healthcare.
Six UK universities receive grant for research into motor neurone disease
The grant was given by the Medical Research Council and the National Institute for Health and Care Research, along with charities LifeArc, MND Association, My Name’5 Doddie Foundation and MND ... The grant was awarded by the Medical Research Council
Latest news
-
LifeArc partners with UK Dementia Research Institute
LifeArc, a self-funded medical research charity, has pledged a £30m investment over the course of five years to the UK DRI. ... The partnership will allow UK DRI scientists access to LifeArc’s therapeutic and diagnostic platforms to support them in
-
LifeArc creates £10m COVID-19 research fund
Medical research charity joins efforts against coronavirus. UK-based medical research charity LifeArc has launched a £10m fund in support of research efforts against the novel coronavirus, which causes the disease ... There is a clear, urgent need now
-
LifeArc takes $30m equity stake in Kymab, gains access to antibody tech
LifeArc is to make an initial $10m equity investment in Kymab, with a further $20m to follow. ... Kymab will also receive a percentage of revenues from any products discovered and commercialised by LifeArc using its technologies.
-
Research charity LifeArc cashes $1.2bn royalty from Keytruda
LifeArc is now making the most of its significant contribution to the drug’s development. ... For LifeArc, the money opens up new possibilities in the translational medicine field.
-
Medicines Discovery Catapult to collaborate with LifeArc on new biomarkers
Will also advance proteomics research. The UK’s Medicines Discovery Catapult has teamed up with LifeArc in a bid to develop novel biomarkers and optimise the medical charity's drug development. ... LifeArc will fund a select number of full-time
More from news
Approximately 4 fully matching, plus 3 partially matching documents found.
Latest Intelligence
-
LifeArc’s challenge to combat bronchiectasis
Further information is available on the LifeArc website (visit www.lifearc.org). Catherine Kettleborough is Chronic Respiratory Infection Translational Challenge Leader at LifeArc. ... Catherine Kettleborough is Chronic Respiratory Infection
-
25 Women Leaders in UK Healthcare
Today Melanie is chief executive of the medical research charity LifeArc, which she joined late last year, and which is about to transformed by a $1.29bn royalty deal based on ... I left the industry to be able to facilitate that, and that’s what
More from intelligence
Approximately 1 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
The RARE Youth Revolution has begun
LifeArc. Sobi. “We are a proud supporter of RARE Youth Revolution and we are absolutely thrilled to have them as part of the Breaking Down Barriers project!
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
- Market Access Director, six figure base salary and £5K joining b...
- Highly competitive salary
- Account Manager, Healthcare Marketing Creative Agency, Fixed ter...
- Highly competitive salary
- Account Manager, 6 month contract, Healthcare Brand communicatio...
- Highly competitive salary
- Home Based Account Manager, Medical Communications, UK, Pharma/M...
- Highly competitive salary
- Senior Medical Copywriter - Highly Awarded Advertising Agency
- £50,000 - £60,000 yearly
- Account Director, Healthcare Marketing Creative Agency, Fixed te...
- Highly competitive salary
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
- Pfizer’s antibiotic combination shows promise in treating multi-drug resistant infections
- Sanofi's frexalimab shows promise in relapsing forms of MS
- BMS presents positive four-year results for Opdivo combination in lung cancer
- Pfizer reports positive results for elranatamab in multiple myeloma
- Amgen reports positive results for Otezla in psoriatic arthritis
- Merck sues US government over Medicare drug price negotiation programme
- GSK’s RSV vaccine approved by EC for older adults
- The 17th World Congress on Controversies in Neurology
- Medscape Education is Focusing on Patient Centricity and Education Outcomes at EHA 2023
- Pfizer reports positive results for elranatamab in multiple myeloma
- Amgen’s Lumakras shows promise in phase 3 lung cancer study
No results were found
PMHub
CHASE
We are a leading provider of outsourced commercial, medical and recruitment services to UK pharmaceutical, biotech and healthcare companies....
Latest intelligence
- The 17th World Congress on Controversies in Neurology
- This year, there was a focus on the rare disease neuromyelitis optica spectrum disorder that strikes suddenly and mainly impacts women...
- Archetypes: Rethinking go-to-market expectations to drive commercial success
- In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...
- Tuberculosis – why it remains a major global public health challenge
- Innovative collaboration is required to address the major public health challenges around TB and expedite drug development...
